Cellectis S.A completes follow-on

Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS), Paris, France Business: Gene/Cell therapy, Genomics Date completed: 2015-03-25 Type: Follow-on Raised: $228.3 million Shares: 5.5 million Price: $41.50 Sh...